Article Details
Retrieved on: 2021-04-09 05:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Exscientia, a leading artificial intelligence (AI)-driven pharmatech company, today announced the first AI-designed molecule for immuno-oncology to ...
Article found on: www.oaoa.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here